Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ESMO 2014 - Immuno-Oncology
Nivolumab versus Investigator’s Choice of Chemotherapy in Patients with Advanced Melanoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
Nivolumab Improves Survival in Ipilimumab-Naïve Patients with Advanced Melanoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
Two Dosing Schedules of Pembrolizumab for Patients with Advanced Melanoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
Updated OS Data for the CA184-043 Trial: Immunotherapy with Ipilimumab Does Not Improve Survival in Patients with Metastatic Prostate Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
Anti–PD-L1 Monoclonal Antibody MPDL3280A in Metastatic Urothelial Bladder Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
Long-Term Follow-Up Results of MPDL3280A in Metastatic Renal-Cell Carcinoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
Dose-Ranging Phase 2 Results of Nivolumab Therapy in Metastatic Renal-Cell Carcinoma
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
Pembrolizumab in the Treatment of Patients with Advanced Urothelial Tract Cancer
ESMO 2014 - Immuno-Oncology
,
ESMO
Conference Correspondent
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma